AcelRx Pharmaceuticals Stock News

Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVATM (eravacycline f

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 27) ADC Therapeutics SA (NYSE:...

Details of the first DOD order for DSUVIA were finally revealed. The initial order of $30M for the Army over three years is small, but it's a sign of things to

ACRX confirmed final agreement with its cornerstone client, the US Army. Sales from DSUVIA still need to pick up. But reports from doctors using DSUVIA on their

Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline Xerava™ (eravacycline fo

May 20, 2020 (HTF Market Intelligence via COMTEX) -- AMA Research added a comprehensive research document of 200+ pages on 'Sinus Dilation Devices' market...

Q1 2020 AcelRx Pharmaceuticals Inc Earnings Call

With me today are Vince Angotti, our Chief Executive Officer; and Dr. Pam Palmer, our Chief Medical Officer. Also, on the call with us today is Dr. Christian Tvetenstrand, who is the Chairman of Surg

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q1 2020 Results Earnings Conference Call May 11, 2020, 04:30 PM ET Company Participants Raffi Asadorian - CFO Vince A

AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises of -33.33% and -85.43%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stoc

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised setti

Merger activity increased last week with three new deals announced. The merger of Quintana Energy Services and KLX Energy Services Holdings. Front Yard Resident